The incidence, risk factors, and outcomes of acute kidney injury after minor lower-limb amputations.

IF 1 4区 医学 Q3 UROLOGY & NEPHROLOGY
Stefanie Marie Agius, Deborah Balzan, Kevin Cassar, Jesmar Buttigieg
{"title":"The incidence, risk factors, and outcomes of acute kidney injury after minor lower-limb amputations.","authors":"Stefanie Marie Agius, Deborah Balzan, Kevin Cassar, Jesmar Buttigieg","doi":"10.5414/CN111832","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aims: </strong>Minor lower-limb amputations are limb and potentially life-saving procedures. However, they are associated with serious adverse events, including acute kidney injury (AKI).</p><p><strong>Materials and methods: </strong>We conducted a single-center retrospective study to determine the incidence of AKI after these procedures, identify risk factors, and assess impact on patient survival.</p><p><strong>Results: </strong>We included 201 patients. AKI occurred in 18.9% using AKIN criteria, and 24.9% using KDIGO criteria. Only 1 patient required temporary dialysis. Patients with AKI were older (73.0 ± 10.4 vs. 68.5 ± 11.8 years, p = 0.033), had a higher incidence of chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73m<sup>2</sup> (39.5 vs. 14.7%, p = 0.001), and/or chronic obstructive pulmonary disease (COPD) (28.9 vs. 13.5% p = 0.028), and higher use of diuretics (68.4 vs. 49.1%, p = 0.049), fluoroquinolones (71.1 vs. 52.8% p = 0.047), and/or carbapenems (10.5 vs. 2.5%, p = 0.043) compared to patients without AKI. eGFR < 45 mL/min/1.73m<sup>2</sup> (OR: 3.24, CI: 1.40 - 7.52, p = 0.006), use of fluoroquinolones (OR: 3.19, CI: 1.30 - 7.82, p = 0.012), and day-1 C-reactive protein (CRP) (OR: 1.01, CI: 1.00 - 1.01, p = 0.009) were established as independent risk factors for AKI. Cumulative survival was not significantly lower in patients with AKI (log rank: 0.02, p = 0.88).</p><p><strong>Conclusion: </strong>AKI is a potential complication following minor lower-limb amputations. Age, COPD, diuretics, fluoroquinolones, and carbapenems were associated with increased incidence of AKI. An eGFR < 45 mL/min/1.73m<sup>2</sup>, day-1 C-reactive protein, and fluoroquinolone use were identified as independent risk factors for AKI.</p>","PeriodicalId":10396,"journal":{"name":"Clinical nephrology","volume":" ","pages":""},"PeriodicalIF":1.0000,"publicationDate":"2025-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5414/CN111832","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and aims: Minor lower-limb amputations are limb and potentially life-saving procedures. However, they are associated with serious adverse events, including acute kidney injury (AKI).

Materials and methods: We conducted a single-center retrospective study to determine the incidence of AKI after these procedures, identify risk factors, and assess impact on patient survival.

Results: We included 201 patients. AKI occurred in 18.9% using AKIN criteria, and 24.9% using KDIGO criteria. Only 1 patient required temporary dialysis. Patients with AKI were older (73.0 ± 10.4 vs. 68.5 ± 11.8 years, p = 0.033), had a higher incidence of chronic kidney disease (CKD); estimated glomerular filtration rate (eGFR) < 45 mL/min/1.73m2 (39.5 vs. 14.7%, p = 0.001), and/or chronic obstructive pulmonary disease (COPD) (28.9 vs. 13.5% p = 0.028), and higher use of diuretics (68.4 vs. 49.1%, p = 0.049), fluoroquinolones (71.1 vs. 52.8% p = 0.047), and/or carbapenems (10.5 vs. 2.5%, p = 0.043) compared to patients without AKI. eGFR < 45 mL/min/1.73m2 (OR: 3.24, CI: 1.40 - 7.52, p = 0.006), use of fluoroquinolones (OR: 3.19, CI: 1.30 - 7.82, p = 0.012), and day-1 C-reactive protein (CRP) (OR: 1.01, CI: 1.00 - 1.01, p = 0.009) were established as independent risk factors for AKI. Cumulative survival was not significantly lower in patients with AKI (log rank: 0.02, p = 0.88).

Conclusion: AKI is a potential complication following minor lower-limb amputations. Age, COPD, diuretics, fluoroquinolones, and carbapenems were associated with increased incidence of AKI. An eGFR < 45 mL/min/1.73m2, day-1 C-reactive protein, and fluoroquinolone use were identified as independent risk factors for AKI.

轻度下肢截肢后急性肾损伤的发生率、危险因素和结局。
背景和目的:轻微下肢截肢是一种截肢和潜在的救生手术。然而,它们与严重的不良事件有关,包括急性肾损伤(AKI)。材料和方法:我们进行了一项单中心回顾性研究,以确定这些手术后AKI的发生率,确定危险因素,并评估对患者生存的影响。结果:纳入201例患者。使用AKIN标准AKI发生率为18.9%,使用KDIGO标准AKI发生率为24.9%。只有1例患者需要临时透析。AKI患者年龄较大(73.0±10.4岁比68.5±11.8岁,p = 0.033),慢性肾脏疾病(CKD)发病率较高;估计肾小球滤过率(eGFR) 2 (39.5 vs. 14.7%, p = 0.001),和/或慢性阻塞性肺疾病(COPD) (28.9 vs. 13.5% p = 0.028),以及与没有AKI的患者相比,利尿剂(68.4 vs. 49.1%, p = 0.049)、氟喹诺酮类药物(71.1 vs. 52.8% p = 0.047)和/或碳青霉烯类药物(10.5 vs. 2.5%, p = 0.043)的使用更高。eGFR 2 (OR: 3.24, CI: 1.40 ~ 7.52, p = 0.006)、使用氟喹诺酮类药物(OR: 3.19, CI: 1.30 ~ 7.82, p = 0.012)和第1天c反应蛋白(CRP) (OR: 1.01, CI: 1.00 ~ 1.01, p = 0.009)被确定为AKI的独立危险因素。AKI患者的累积生存期没有显著降低(log rank: 0.02, p = 0.88)。结论:AKI是轻微下肢截肢后的潜在并发症。年龄、COPD、利尿剂、氟喹诺酮类药物和碳青霉烯类药物与AKI发病率增加相关。eGFR 2、day-1 c反应蛋白和氟喹诺酮类药物的使用被确定为AKI的独立危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Clinical nephrology
Clinical nephrology 医学-泌尿学与肾脏学
CiteScore
2.10
自引率
9.10%
发文量
138
审稿时长
4-8 weeks
期刊介绍: Clinical Nephrology appears monthly and publishes manuscripts containing original material with emphasis on the following topics: prophylaxis, pathophysiology, immunology, diagnosis, therapy, experimental approaches and dialysis and transplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信